PUBLICATIONS · 33844595
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Aug 1
- First author
- Alva AS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2021 Aug 1;39(22):2426-2429. doi: 10.1200/JCO.21.00552.
- note
- Source null
- related pmid
- 33979191
- relationship
- Comment in
Authors and identifiers
- name
- Alva AS
- type
- Author
- name
- Mangat PK
- type
- Author
- name
- Garrett-Mayer E
- type
- Author
- name
- Halabi S
- type
- Author
- name
- Hansra D
- type
- Author
- name
- Calfa CJ
- type
- Author
- name
- Khalil MF
- type
- Author
- name
- Ahn ER
- type
- Author
- name
- Cannon TL
- type
- Author
- name
- Crilley P
- type
- Author
- name
- Fisher JG
- type
- Author
- name
- Haslem DS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Alva AS
- type
- Author
- name
- Mangat PK
- type
- Author
- name
- Garrett-Mayer E
- type
- Author
- name
- Halabi S
- type
- Author
- name
- Hansra D
- type
- Author
- name
- Calfa CJ
- type
- Author
- name
- Khalil MF
- type
- Author
- name
- Ahn ER
- type
- Author
- name
- Cannon TL
- type
- Author
- name
- Crilley P
- type
- Author
- name
- Fisher JG
- type
- Author
- name
- Haslem DS
- type
- Author
- bibliography ids
- nci-bib-51731cc5e123c7d21e548e40
- book metadata
- content sha256
- b8b658ee64d871118de13ba899480ff2995acd208323a60d7c016c1e6619fc5f
- document type
- citation
- dois
- 10.1200/JCO.20.02923
- electronic publication date
- display
- 2021 Apr 12
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33844595
- immutable id
- pubmed:33844595@b8b658ee64d871118de13ba899480ff2995acd208323a60d7c016c1e6619fc5f
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 22
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2443-2451
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2021 Aug 1;39(22):2426-2429. doi: 10.1200/JCO.21.00552.
- note
- Source null
- related pmid
- 33979191
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 33844595
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 0e1afe57f075fc3a537b43258c8745d51cefc254ba552d7591a8d31d00829454
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Aug 1
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Preserved source evidence · Not medical advice
Triangle